Pamidronate disodium salt

CAS No. 57248-88-1

Pamidronate disodium salt( APD | CGP 23339A | Pamidronic Acid )

Catalog No. M15087 CAS No. 57248-88-1

Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 74 In Stock
50MG 124 In Stock
100MG 178 In Stock
200MG 267 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pamidronate disodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.
  • Description
    Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    APD | CGP 23339A | Pamidronic Acid
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HAP| FPPS
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    57248-88-1
  • Formula Weight
    279.03
  • Molecular Formula
    C3H9NNa2O7P2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 56 mg/mL (200.69 mM)
  • SMILES
    OC(OP([O-])=O)(OP([O-])=O)CCN.[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[Na+].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bergstrom JD, et al. Arch Biochem Biophys. 2000 Jan 1;373(1):231-4
molnova catalog
related products
  • Lagociclovir

    Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.

  • BCM-599

    BCM-599 is an efficient HBV capsid assembly inhibitor with in vitro IC50 of 13 uM, shows synergistic inhibitory effects on decreasing viral concentration combined with lamivudine in vivo.

  • Bay 41-4109

    A potent, non-nucleosidic inhibitor of HBV nucleocapsid maturation with IC50 of 0.05 uM.